Overview Financials News + Filings Key Docs Ownership Insiders
All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other
Tags
Quarterly results
|
|
Vigil Neuroscience, Inc.
|
Create: Alert |
All | News | Filings
| Date Filed | Type | Description |
| 08/07/2023 |
4
| Silber Christopher (Chief Medical Officer) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 330,000 options to buy
@ $6.16, valued at
$2M
|
|
| 06/09/2023 |
4
| Bruhn Suzanne Louise (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
| 06/09/2023 |
4
| Thistle Mary (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
| 06/09/2023 |
4
| Koenig Gerhard (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
| 06/09/2023 |
4
| Blanchard Cheryl R (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
| 06/09/2023 |
4
| Vitorovic Stefan (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
| 06/09/2023 |
4
| Booth Bruce (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
| 06/09/2023 |
4
| Budd Haeberlein Samantha L. (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 13,928 options to buy
@ $10, valued at
$139.3k
|
|
| 05/09/2023 |
4
| Budd Haeberlein Samantha L. (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 30,694 options to buy
@ $9.65, valued at
$296.2k
|
|
| 02/27/2023 |
4
| Gray David L. F. (Chief Science Officer) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 267,000 options to buy
@ $12.09, valued at
$3.2M
|
|
| 11/22/2022 |
4
| Papapetropoulos Spyros (Chief Medical Officer) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Sold 300 shares
@ $14, valued at
$4.2k
Exercised 300 options to buy
@ $1.89, valued at
$567 |
|
| 07/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Vitorovic Stefan (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 12,155 options to buy
@ $3.1, valued at
$37.7k
|
|
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/13/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/17/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 05/06/2022 |
4
| Thackaberry Evan (SVP, Head of Early Development) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Bought 1,500 shares
@ $4, valued at
$6k
|
|
| 05/04/2022 |
4
| Verni Christopher (General Counsel) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Bought 4,000 shares
@ $3.7686, valued at
$15.1k
|
|
| 05/04/2022 |
4
| Magovcevic-Liebisch Ivana (President and CEO) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Bought 4,000 shares
@ $3.6097, valued at
$14.4k
Bought 1,000 shares
@ $3.9402, valued at
$3.9k
|
|
| 05/04/2022 |
4
| Ziolkowski Jennifer Lynn (CFO) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Bought 4,000 shares
@ $3.7744, valued at
$15.1k
|
|
| 05/04/2022 |
4
| Papapetropoulos Spyros (Chief Medical Officer) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Bought 4,000 shares
@ $3.3978, valued at
$13.6k
|
|
| 04/20/2022 |
4
| Verni Christopher (General Counsel) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 150,000 options to buy
@ $7.06, valued at
$1.1M
|
|
| 04/20/2022 |
4
| Thistle Mary (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Granted 24,309 options to buy
@ $6.8, valued at
$165.3k
|
|
| 03/28/2022 |
4
| Thorp Clay (Director) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Bought 3,000 shares
@ $7.2014, valued at
$21.6k
|
|
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 03/03/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/13/2022 |
4
| Cormorant Asset Management, LP (Former 10% Owner) has filed a Form 4 on Vigil Neuroscience, Inc.|
Txns:
| Converted 616,786 shares
@ $0
Converted 616,786 convertible preferred
@ $0 |
|
|
|
|